Endovascular therapy adds no value in basilar-artery stroke: trial
The study of 300 patients finds trends 'in the right direction' but no statistically significant results
A trial of endovascular therapy in patients with a basilar-artery occlusion has failed to prove direct clot removal produces a better functional outcome than standard medical therapy.
In the randomised trial of 300 patients, reported in The New England Journal of Medicine, 44.2% of those assigned to endovascular treatment had a favourable function outcome compared with 37.7% of those in the medical care group.
